Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

Felip E, Kuo P, Garrido P, Chouaid C, Mountzios G, Tiseo M, Daniel DB, Zavodovskaya M, Tang S, Su-Feher L, Patel R, Park JK, Jürgensmeier JM, Summers Y

Open source

DOI: 10.1158/2767-9764.crc-26-0070
Published: 2026 Aug 1
Container: Cancer research communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0070,
  title = {Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.},
  author = {Felip E and Kuo P and Garrido P and Chouaid C and Mountzios G and Tiseo M and Daniel DB and Zavodovskaya M and Tang S and Su-Feher L and Patel R and Park JK and Jürgensmeier JM and Summers Y},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-26-0070},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0070}
}

RIS

TY  - JOUR
TI  - Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.
AU  - Felip E
AU  - Kuo P
AU  - Garrido P
AU  - Chouaid C
AU  - Mountzios G
AU  - Tiseo M
AU  - Daniel DB
AU  - Zavodovskaya M
AU  - Tang S
AU  - Su-Feher L
AU  - Patel R
AU  - Park JK
AU  - Jürgensmeier JM
AU  - Summers Y
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-26-0070
UR  - https://doi.org/10.1158/2767-9764.crc-26-0070
ER  -

APA

E, F., P, K., P, G., C, C., G, M., M, T., DB, D., M, Z., S, T., L, S., R, P., JK, P., JM, J., & Y, S. (2026). Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0070

Source records

pubmed · retrieved 2026-09-26T15:21:20.564Z